References
- ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ20048284485115640920
- QuigleyHAGlaucomaLancet20113771367137721453963
- ChauhanBCMikelbergFSBalasziAGCanadian Glaucoma Study: risk factors for the progression of open-angle glaucomaArch Ophthalmol20081261030103618695095
- HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
- European Glaucoma SocietyTerminology and Guidelines for Glaucoma3rd edSavona, ItalyEditrice Dogma2008
- Advanced Glaucoma Intervention StudyThe Advanced Glaucoma Intervention Study (AGIS): the relationship between control of intraocular pressure and visual field deterioration. The AGIS InvestigatorsAm J Ophthalmol200013042944011024415
- AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma20081766767319092464
- van der ValkVWebersCALumleyTA network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressureJ Clin Epidemiol2009621279128319716679
- DenisPLafumaAKhoshnoodBMimaudVBerdeauxGA meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapyCurr Med Res Opin20072360160817355741
- WirtaDVan DenburghAMWengELong-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsClin Ophthalmol2011575976521691584
- ZimmermanTJHahnSRGelbLTanHKimEEThe impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistenceJ Ocul Pharmacol Ther20092514515219284321
- KatzLJCohenJSBatoosinghALTwelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertensionAm J Ophthalmol201014966167120346780
- Allergan Ltd.Lumigan prescribing information Available at: http://www.allergan.com/assets/pdf/lumigan_pi.pdfAccessed March 28, 2012
- WilliamsRDCohenJSGrossRLLong-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4Br J Ophthalmol2008921387139218621791
- GordonMOBeiserJABrandtJDThe Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol200212071472012049575
- OlthoffCMSchoutenJSvan de BorneBWWebersCANoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology200511295396115885795